Laropiprant/Simvastatin/Nicotinic Acid
- Generic Name
- Laropiprant/Simvastatin/Nicotinic Acid
MK-0524B Lipid Study (MK-0524B-063)
Phase 3
Completed
- Conditions
- Primary HypercholesterolemiaMixed Dyslipidemia
- Interventions
- First Posted Date
- 2007-05-28
- Last Posted Date
- 2019-02-06
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 2414
- Registration Number
- NCT00479882
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath